Cargando…
Antisense oligonucleotide inhibition of hepatitis C virus genotype 4 replication in HepG2 cells
BACKGROUND: Hepatitis C (HCV) viral infection is a serious medical problem in Egypt and it has a devastating impact on the Egyptian economy. It is estimated that over 15% of Egyptians are infected by the virus and thus finding a cure for this disease is of utmost importance. Current therapies for he...
Autores principales: | El Awady, Mostafa K, El Din, Noha G Badr, El Garf, Wael T, Youssef, Samar S, Omran, Moataza H, El Abd, Jasmin, Goueli, Said A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1524817/ https://www.ncbi.nlm.nih.gov/pubmed/16803625 http://dx.doi.org/10.1186/1475-2867-6-18 |
Ejemplares similares
-
In Vitro Inhibition of Hepatitis C Virus by Antisense Oligonucleotides in PBMC Compared to Hepatoma Cells
por: Youssef, Samar Samir, et al.
Publicado: (2014) -
Soluble egg antigen of Schistosoma Haematobium induces HCV replication in PBMC from patients with chronic HCV infection
por: El-Awady, Mostafa K, et al.
Publicado: (2006) -
Heterogeneity and New Epitopes of Hepatitis C Virus Genotype 4
por: Omran, Moataza H., et al.
Publicado: (2013) -
A Study of CC-Chemokine Receptor 5 (CCR5) Polymorphism on the Outcome of HCV Therapy in Egyptian Patients
por: Omran, Moataza H, et al.
Publicado: (2013) -
Antiproliferative and apoptotic effects of β-elemene on human hepatoma HepG2 cells
por: Dai, Zhi-Jun, et al.
Publicado: (2013)